Neelam, Ameera, and Anand Kanaki. 2021. “Efficacy and Safety of Remogliflozin Etabonate in Type 2 Diabetes Mellitus Patients in a Tertiary Care Hospital”. International Journal of Basic & Clinical Pharmacology 10 (4):353-56. https://doi.org/10.18203/2319-2003.ijbcp20211014.